Summary of Key Points Core Viewpoint - Baicheng Pharmaceutical (301096.SZ) experienced a significant decline in stock price, closing at 55.99 yuan with a drop of 9.03%, indicating a state of breaking down [1]. Company Overview - Baicheng Pharmaceutical was listed on the Shenzhen Stock Exchange's ChiNext board on December 20, 2021, with an initial issuance of 27.04 million shares at a price of 79.60 yuan per share [1]. - The stock reached a peak price of 120 yuan on its first trading day, marking the highest price since its listing [1]. Fundraising Details - The total amount raised from the initial public offering (IPO) was 2.153 billion yuan, with a net amount of 1.863 billion yuan after deducting issuance costs [1]. - The net amount raised exceeded the original plan by 1.213 billion yuan, as the company initially aimed to raise 651 million yuan for its headquarters and R&D center in Hangzhou [1]. - The total issuance costs for the IPO were 289 million yuan, which included underwriting and sponsorship fees of 262 million yuan [1].
百诚医药跌9.03% 2021年上市即巅峰超募12亿